Stockscreener 앱 받기
14.35
2.05%
-0.30
전일 마감가:
$14.65
열려 있는:
$14.6
하루 거래량:
670.51K
Relative Volume:
0.87
시가총액:
$1.51B
수익:
-
순이익/손실:
$-150.70M
주가수익비율:
-9.2581
EPS:
-1.55
순현금흐름:
$-125.67M
1주 성능:
-3.37%
1개월 성능:
+2.87%
6개월 성능:
-45.62%
1년 성능:
-22.10%
1일 변동 폭
$14.12
$14.70
1주일 범위
$13.93
$14.94
52주 변동 폭
$10.60
$38.12
엣지와이즈 Stock (EWTX) Company Profile
명칭
Edgewise Therapeutics Inc
전화
720-262-7002
주소
1715 38TH ST, BOULDER
EWTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EWTX
Edgewise Therapeutics Inc
|
14.35 | 1.54B | 0 | -150.70M | -125.67M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
엣지와이즈 Stock (EWTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-30 | 개시 | Raymond James | Strong Buy |
| 2025-06-30 | 개시 | H.C. Wainwright | Buy |
| 2025-04-30 | 개시 | Guggenheim | Buy |
| 2025-04-02 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2025-01-22 | 개시 | Stifel | Hold |
| 2024-11-22 | 개시 | Evercore ISI | Outperform |
| 2024-03-07 | 개시 | Piper Sandler | Overweight |
| 2023-05-01 | 개시 | Truist | Buy |
| 2022-08-25 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-04-13 | 개시 | RBC Capital Mkts | Outperform |
| 2022-01-28 | 개시 | Goldman | Neutral |
모두보기
엣지와이즈 주식(EWTX)의 최신 뉴스
Using economic indicators to assess Edgewise Therapeutics Inc. potentialJuly 2025 Outlook & Consistent Profit Alerts - Newser
Analyzing drawdowns of Edgewise Therapeutics Inc. with statistical toolsWeekly Trade Report & Verified Stock Trade Ideas - Newser
202,580 Shares in Edgewise Therapeutics, Inc. $EWTX Purchased by Nuveen LLC - MarketBeat
What’s the recovery path for long term holders of Edgewise Therapeutics Inc.July 2025 Snapshot & AI Enhanced Market Trend Forecasts - Newser
Edgewise Therapeutics, Inc. $EWTX Shares Acquired by Siren L.L.C. - MarketBeat
Key resistance and support levels for Edgewise Therapeutics Inc.Price Action & Precise Entry and Exit Recommendations - Newser
Regression analysis insights on Edgewise Therapeutics Inc. performancePortfolio Risk Report & Smart Swing Trading Alerts - Newser
Volume spikes in Edgewise Therapeutics Inc. stock – what they meanJuly 2025 PreEarnings & AI Enhanced Trade Execution Alerts - Newser
Will Edgewise Therapeutics Inc. stock go up soon2025 Top Gainers & Smart Investment Allocation Tips - Newser
What moving averages say about Edgewise Therapeutics Inc.Buy Signal & Reliable Volume Spike Trade Alerts - Newser
Published on: 2025-08-30 20:31:50 - Newser
Heatmap analysis for Edgewise Therapeutics Inc. and competitorsMarket Volume Report & High Accuracy Trade Signal Alerts - Newser
Will breakout in Edgewise Therapeutics Inc. lead to full recoveryMarket Rally & Free Risk Controlled Daily Trade Plans - Newser
What earnings revisions data tells us about Edgewise Therapeutics Inc.Weekly Market Report & AI Optimized Trade Strategies - Newser
Edgewise Therapeutics Inc. stock chart pattern explainedTrade Analysis Report & Risk Controlled Daily Trade Plans - Newser
Is Edgewise Therapeutics Inc. stock poised for growthQuarterly Portfolio Summary & Daily Entry Point Alerts - Newser
Chart based exit strategy for Edgewise Therapeutics Inc.IPO Watch & Expert Curated Trade Ideas - Newser
Published on: 2025-08-29 19:13:04 - Newser
How Edgewise Therapeutics Inc. stock performs during market volatilityM&A Rumor & Safe Swing Trade Setups - Newser
Can trapped investors hope for a rebound in Edgewise Therapeutics Inc.July 2025 Summary & Free Safe Entry Trade Signal Reports - Newser
Quantitative breakdown of Edgewise Therapeutics Inc. recent moveEarnings Beat & Precise Buy Zone Identification - Newser
Brokerages Set Edgewise Therapeutics, Inc. (NASDAQ:EWTX) PT at $40.55 - MarketBeat
Published on: 2025-08-29 15:50:13 - Newser
What is the target price for Edgewise Therapeutics Inc. stockPortfolio Growth Summary & High Win Rate Trade Tips - sundaytimes.kr
Sentiment analysis tools applied to Edgewise Therapeutics Inc.2025 Price Action Summary & Weekly Stock Performance Updates - Newser
How to build a dashboard for Edgewise Therapeutics Inc. stockPortfolio Profit Report & Community Supported Trade Ideas - Newser
Intraday pattern recognizer results for Edgewise Therapeutics Inc.July 2025 Decliners & Momentum Based Trading Signals - Newser
Published on: 2025-08-29 11:38:03 - Newser
Applying Wyckoff theory to Edgewise Therapeutics Inc. stockJuly 2025 Technicals & Fast Moving Trade Plans - Newser
Edgewise Therapeutics Insider Makes Major Stock Sale Amid Q2 Earnings Report and Analyst Coverage - AInvest
Edgewise Therapeutics Inc. Approaches Support With Recovery in Sight getLinesFromResByArray error: size == 0 - newsyoung.net
Edgewise Therapeutics, Inc. $EWTX Holdings Reduced by Vanguard Group Inc. - MarketBeat
엣지와이즈 (EWTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.96%
1.09%
자본화:
|
볼륨(24시간):